Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

3.19
-0.1100-3.33%
Volume:347.78K
Turnover:1.11M
Market Cap:363.66M
PE:-2.40
High:3.34
Open:3.32
Low:3.13
Close:3.30
52wk High:6.16
52wk Low:1.96
Shares:114.00M
Float Shares:67.93M
Volume Ratio:0.51
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.3971
ROE:-39.57%
ROA:-22.28%
PB:1.12
PE(LYR):-2.28

Loading ...

OverviewCompanyNewsFilings

Perspective Therapeutics Inc : RBC Cuts Target Price to $14 From $18

THOMSON REUTERS
·
Mar 17

Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress

TIPRANKS
·
Mar 17

Perspective Therapeutics Q4 EPS $(0.51) Misses $(0.36) Estimate, Sales $43.000K Miss $215.615K Estimate.

Benzinga Earnings
·
Mar 17

Perspective Therapeutics FY 2025 net loss widens 30.1% to USD 103.12 million as R&D expenses more than doubled to USD 84.22 million

Reuters
·
Mar 17

BRIEF-Perspective Therapeutics FY EPS USD -1.4

Reuters
·
Mar 17

Perspective Therapeutics FY Net Income From Cont Ops USD -104.428 Million

THOMSON REUTERS
·
Mar 17

Press Release: Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results

Dow Jones
·
Mar 17

Wedbush Sticks to Their Buy Rating for Perspective Therapeutics (CATX)

TIPRANKS
·
Mar 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Mar 12

Analyst Rate

Buy
Buy
93.33%
Hold
6.67%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 10, 2026 Post-Mkt
Financial Report Announcement
May 11, 2026 Post-Mkt
Financial Report Announcement
Mar 16, 2026 Post-Mkt
Financial Report Announcement
Nov 10, 2025 Post-Mkt
Financial Report Announcement
Aug 13, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.48
Current
-8.61
Sector Average
77.86%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.48
Maximum
-1.45
+1 STD
-2.02
Minimum
-28.55
-1 STD
-15.20
Average
-8.61

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.